Verrica Pharmaceuticals announces resubmission of new drug application for VP-102 for the treatment of molluscum contagiosum

Verrica Pharmaceuticals

24 January 2023 - Potential first FDA approved therapy for treatment of molluscum contagiosum.

Verrica Pharmaceuticals today announced that it has resubmitted the new drug application for VP-102 for the treatment of molluscum contagiosum (molluscum) to the US FDA.

Read Verrica Pharmaceuticals press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Dossier